The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of carboplatin/paclitaxel and cetuximab, followed by carboplatin/paclitaxel/cetuximab and erlotinib, in metastatic or recurrent squamous cell carcinoma of the head and neck.
 
Aarti K. Bhatia
Consulting or Advisory Role - Boehringer Ingelheim
 
Ranee Mehra
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Genentech
Travel, Accommodations, Expenses - Mirati Therapeutics
 
Saad A. Khan
Research Funding - Bayer/Onyx (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Threshold Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Novartis
 
Brian L. Egleston
Research Funding - Verilogue (Inst)
 
R. Katherine Alpaugh
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - An inflammatory breast cancer cell line was established and is being provided by Fox Chase Cancer Center for research purposes. Royalities are recieved yearly dependent on the number of requests.
 
Miriam Lango
No Relationships to Disclose
 
John A. Ridge
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - MedImmune; Merck; Novartis; VentiRx
Research Funding - Genentech; Merck
Expert Testimony - Johnson & Johnson